Navigation Links
Inhaled Meds May Save COPD/Pneumonia Patients' Lives
Date:4/20/2011

WEDNESDAY, April 20 (HealthDay News) -- Inhaled corticosteroids can actually reduce the risk of death in patients with chronic obstructive pulmonary disease, or COPD, who are hospitalized with pneumonia, a new study has found.

U.S. researchers examined the medical records of 15,768 COPD patients older than 65 who were admitted to VA hospitals for pneumonia between 2002 and 2007. Of those patients, 52.5 percent were treated with inhaled corticosteroids.

The all-cause death rate after 30 days was 10.2 percent for inhaled corticosteroid users and 13.6 percent for those who weren't treated with inhaled corticosteroids. After 90 days, the death rate was 17.3 percent among inhaled corticosteroid users and 22.8 percent for those who didn't receive inhaled corticosteroids, the investigators found.

Overall, patients not treated with inhaled corticosteroids were about 25 percent more likely to die than those who received the medication, the researchers concluded.

The study findings were released online in advance of publication in an upcoming print issue of the American Journal of Respiratory and Critical Care Medicine.

Previous research found that inhaled corticosteroid use in COPD patients increases the risk of pneumonia. It was therefore believed that inhaled corticosteroids also increased the risk of death in these patients. This study found the opposite to be true.

"These results have clear implications for current clinical practice, which has been informed in the past by a series of studies that found an increased risk of pneumonia with inhaled corticosteroid use," principal investigator Dr. Eric Mortensen, an investigator at the Veterans Evidence-Based Research, Dissemination, and Implementation Center (VERDICT), a VA Health Services research and development program, said in a news release from the American Thoracic Society.

"In contrast, our study would suggest that inhaled corticosteroid use
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. New Inhaled Insulin Shows Promise for Diabetes
2. Inhaled steroids increase diabetes risk, say Lady Davis Institute researchers
3. ICU Patients at Risk for Rare Heart Rhythm Problem
4. Young patients with chronic illnesses find relief in acupuncture
5. For Some Breast Cancer Patients, Shorter Radiation Works Well
6. New Study Uses Adult Stem Cells in Effort to Save Limbs of Patients with Peripheral Arterial Disease
7. Patients with Lethal Lung Disease Finally Receive Recognition by Social Security Administration
8. Behavioral therapy improves sleep and lives of patients with pain
9. Protecting patients: Study shows that Johns Hopkins flu vaccination rates twice national average
10. MSU researcher linking breast cancer patients with alternative therapies
11. New American Heart Association Survey Finds Heart Disease and Stroke Patients Face Significant Barriers in Obtaining Quality, Affordable Care
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Inhaled Meds May Save COPD/Pneumonia Patients' Lives 
(Date:5/29/2015)... Dot Hill can mark one more item off her bucket list: ... retirement community is the oldest woman to have flown at ... great fun!”, she exclaimed. “I’ve always wanted to jump from ... thought this would be ok.” , “We put on nylon coveralls, ... described. “I don’t remember it being noisy, but the wind ...
(Date:5/29/2015)... Los Angeles, CA (PRWEB) May 29, 2015 ... Old Should You Really be When You Get Botox ... anti-aging questions according to Google. Elle partnered with Google to ... these questions. The most searched question in California, for example, ... South Carolina the most common search query is what's the ...
(Date:5/29/2015)... Jan Wooden Howse lost her husband and ... all else: God does no wrong. , It’s fitting, then, ... passing is titled “God Does No Wrong.” It focuses on ... personal tragedy. , “My story has a positive message ... into something productive, something healing,” Howse said. , “God Does ...
(Date:5/29/2015)... 29, 2015 Johnson & Johnson ... confidential Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) settlement with ... to his use of the antipsychotic medication. According ... for the third bellwether trial to involve male ... underway in Pennsylvania’s Philadelphia Court of Common Pleas, ...
(Date:5/29/2015)... Diego, California (PRWEB) May 29, 2015 A ... Core” and have joined the national effort to teach this ... parents in the U.S. have been “sickened” by the recent ... However, love it or hate it, Common Core is now ... District of Columbia. Parents are now seeking ways to ...
Breaking Medicine News(10 mins):Health News:Indoor Skydiving Brings Thrills to Seniors 2Health News:Botox, Wrinkles and Double Chins: The Most-Asked Beauty Problems According to Google 2Health News:Turning grief from a child’s passing into virtue 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:Doctors Discover a Cure for the Common Core 2
... FASgen is pleased to report the,publication of ... one of the Company,s proprietary compounds. In a ... supported,research into the selective inhibition of fatty acid ... potential therapeutic agent against various,forms of solid tumor ...
... KAYSVILLE, Utah, Dec. 28 A Utah company wants ... Virtual Trainer Pro.,MediaRif,s online software takes the complexity out ... Strength training is on the rise, and not just ... reports that 21.9% of women use,strength training as a ...
... KV,s Securities until February 15, ... ... KV Pharmaceutical Company,(NYSE: KVa/KVb) a fully integrated specialty pharmaceutical company ... products,announced today that NYSE Regulation, Inc. has granted KV,s request for ...
... 28 Caraco Pharmaceutical,Laboratories, Ltd., (Amex: CPD ) ... has granted final approval for the Company,s,Abbreviated New Drug ... 5 mg and 10 mg, (Cetirizine HCl)., Cetirizine ... products in,two strengths of 5 mg and 10 mg, ...
... Therapeutics Inc.,("Transition" or the "Company") (TSX: TTH; NASDAQ: ... has been appointed Vice President of,Business Development. Since ... key member of the Company,s management team and ... a broad range of activities,including licensing and intellectual ...
... that contact with some commonly used pesticides in farm work ... women are an understudied occupational group, said Jane Hoppin, Sc.D., ... author of the study. More than half the women in ... about the risks. , The study was published in the ...
Cached Medicine News:Health News:Personal Fitness Training Goes Online for 2008 2Health News:KV Pharmaceutical Company Announces NYSE Listing Extension 2Health News:KV Pharmaceutical Company Announces NYSE Listing Extension 3Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R) 2Health News:Transition Therapeutics Announces Appointment of Vice-President of Business Development 2Health News:Handling pesticides associated with greater asthma risk in farm women 2
(Date:5/29/2015)... MENLO PARK, Calif. , May 29, ... (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical ... therapies in new orphan drug indications, presented additional ... Cancer Research (AACR) Advances in Brain Cancer Research ... product candidate VAL-083 (dianhydrogalactitol) to treat ...
(Date:5/29/2015)... -- World-renowned prostate surgeon and New York Urologist, Dr. David ... MR/Ultrasound Fusion-Guided Biopsy for detecting aggressive prostate cancer ... at Lenox Hill Hospital is the only center using the ... York City . We,ve seen tremendous improvement in detecting ... of an MRI makes for a much more accurate diagnosis, ...
(Date:5/28/2015)... HOUSTON , May 28, 2015 /PRNewswire/ - ESSA Pharma ... results for the second quarter and three and six months ... in Canadian dollars and in accordance with International Financial Reporting ... ESSA recorded a net loss of $5.9 million ($0.35 per ... (Q2-2015), compared to a net loss of $0.4 million ($0.03 ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5MR/Ultrasound Fusion-Guided Biopsy Better Able to Detect Aggressive Prostate Cancer, New Study Says 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5
... 9 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ... with eight presentations (including three oral talks and two ... Scientific Sessions in New Orleans by Isis and its ... ISIS-SGLT2Rx showing a robust and sustained reduction in sodium ...
... for America,s Health (TFAH) and the Robert Wood Johnson ... which finds that Americans rank prevention as the most ... funding for prevention programs to reduce disease and keep ... conducted by Greenberg Quinlan Rosner Research and Public Opinion ...
Cached Medicine Technology:Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions 2Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions 3Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions 4Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions 5Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions 6New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform 2New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform 3New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform 4New Poll Finds Disease Prevention is Top Priority for Americans in Health Reform 5
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: